Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Opinion in Investigational Drugs (London, England : 2000)|September 5, 2002
Duloxetine Eli LillySami Anttila, Esa Leinonen
BMC Psychiatry|May 25, 2007
Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approachSami Anttila, Olli Kampman, Ari Illi, et al.
Neuroreport|May 7, 2004
Association of EGF polymorphism with schizophrenia in Finnish menSami Anttila, Ari Illi, Olli Kampman, et al.
Pharmacogenetics|April 30, 2004
Interaction between NOTCH4 and catechol-O-methyltransferase genotypes in schizophrenia patients with poor response to typical neurolepticsSami Anttila, Ari Illi, Olli Kampman, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 13, 2006
Brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T are not associated with response to electroconvulsive therapy in major depressive disorderKaija Huuhka, Sami Anttila, Martti Huuhka, et al.
The Pharmacogenomics Journal|August 19, 2007
Catechol-O-methyltransferase (COMT) polymorphisms predict treatment response in electroconvulsive therapySami Anttila, Kaija Huuhka, Martti Huuhka, et al.
Journal of Psychiatric Research|August 24, 2005
Epidermal growth factor a61g polymorphism is associated with the age of onset of schizophrenia in male patientsKari Hänninen, Heikki Katila, Sami Anttila, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 23, 2004
Interaction of tumor necrosis alpha - G308A and epidermal growth factor gene polymorphisms in early-onset schizophreniaOlli Kampman, Sami Anttila, Ari Illi, et al.
Neuroscience Letters|May 5, 2009
ACE polymorphism and response to electroconvulsive therapy in major depressionJuhani Akseli Stewart, Olli Kampman, Martti Huuhka, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 6, 2003
Interaction between angiotensin-converting enzyme and catechol-O-methyltransferase genotypes in schizophrenics with poor response to conventional neurolepticsAri Illi, Olli Kampman, Sami Anttila, et al.
Pageof 3